No patients in the placebo group had clinical remission at week @ , compared with eight ( @ % -LSB- @ % CI @-@ -RSB- ) patients in the etrolizumab @ mg group ( p = @ ) and four ( @ % -LSB- @-@ -RSB- ) patients in the @ mg plus LD group ( p = @ ) .